Table 4.
Serological profile of source patients in occupational accidents involving biological material (n = 938) between 2007 and 2016 in the state of Amapá, Brazil
| Known source patient (n = 780) | ||
| Yes | 494 | 63.3 |
| No | 286 | 36.7 |
| Ignored (n = 938) | 158 | 16.8 |
| HBsAg (source patient) (n = 79) | ||
| Negative | 75 | 94.9 |
| Positive | 4 | 5.1 |
| Ignored (n = 938) | 859 | 91.6 |
| Anti-HIV (source patient) (n = 239) | ||
| Negative | 216 | 90.4 |
| Positive | 23 | 9.6 |
| Ignored (n = 938) | 699 | 74.5 |
| Anti-HBc (source patient) (n = 75) | ||
| Negative | 71 | 94.7 |
| Positive | 4 | 5.3 |
| Ignored (n = 938) | 863 | 92.0 |
| Anti-HCV (source patient) (n = 81) | ||
| Negative | 75 | 92.6 |
| Positive | 6 | 7.4 |
| Ignored (n = 938) | 857 | 91.4 |
| Chemoprophylaxis recommendation (n = 341) | ||
| Yes | 188 | 55.1 |
| No | 153 | 44.9 |
| Ignored (n = 938) | 597 | 63.6 |
| Refused chemoprophylaxis (n = 231) | ||
| Yes | 16 | 19.2 |
| No | 215 | 80.8 |
| Ignored (n = 938) | 707 | 75.4 |
| Human immunoglobulin against hepatitis B (n = 211) | ||
| Yes | 23 | 10.9 |
| No | 188 | 89.1 |
| Ignored (n = 938) | 727 | 77.5 |
| Vaccine against hepatitis B (n=251) | ||
| Yes | 69 | 27.5 |
| No | 182 | 72.5 |
| Ignored (n = 938) | 687 | 73.2 |